REPLIGEN CORP RGEN
REPLIGEN CORP financials (annual)
Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $738.3M | $634.4M | $632.4M | $801.5M | $670.5M | $366.3M | $270.2M | $194.0M | $141.2M | $104.5M |
| R&D expense | $54.2M | $43.2M | $42.7M | $43.9M | $34.3M | $20.2M | $19.4M | $15.8M | $8.7M | $7.4M |
| SG&A expense | $290.5M | $263.4M | $218.6M | $215.8M | $183.9M | $119.6M | $95.6M | $65.7M | $51.5M | $30.9M |
| Operating income | $55.2M | -$35.1M | $47.7M | $224.7M | $167.2M | $69.8M | $36.1M | $26.0M | $14.0M | $16.0M |
| Interest expense | — | — | $2.0M | $1.2M | $11.3M | $10.8M | $9.3M | $6.7M | $6.4M | $3.8M |
| Income tax | $13.5M | -$1.5M | $21.1M | $33.2M | $25.3M | -$709,000 | $4.7M | $4.8M | -$21.1M | $11,000 |
| Net income | $48.9M | -$25.5M | $35.6M | $186.0M | $128.3M | $59.9M | $21.4M | $16.6M | $28.4M | $11.7M |
| EPS (diluted) | $0.86 | $-0.46 | $0.63 | $3.24 | $2.24 | $1.11 | $0.44 | $0.37 | $0.72 | $0.34 |
| Operating cash flow | $117.4M | $175.4M | $113.9M | $172.1M | $119.0M | $62.6M | $67.2M | $32.8M | $17.5M | $7.5M |
| Free cash flow | $93.9M | $149.7M | $77.7M | $87.2M | $51.9M | $40.2M | $48.7M | $22.1M | $12.0M | $3.2M |
| Cash & equivalents | $566.0M | $757.4M | $751.3M | $523.5M | $603.8M | $717.3M | $528.4M | $193.8M | $173.8M | $122.2M |
| Inventory | $170.5M | $143.0M | $202.3M | $238.3M | $184.5M | $95.0M | $54.8M | $42.3M | $39.0M | $24.7M |
| Total assets | $2.9B | $2.8B | $2.8B | $2.5B | $2.4B | $1.9B | $1.4B | $774.6M | $743.5M | $288.9M |
| Total liabilities | $843.6M | $856.9M | $866.3M | $614.0M | $608.3M | $373.7M | $340.3M | $159.1M | $152.0M | — |
| Shareholders' equity | $2.1B | $2.0B | $2.0B | $1.9B | $1.8B | $1.5B | $1.1B | $615.6M | $591.5M | $168.8M |
Growth · year-over-year · Revenue CAGR 24.3%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | +16.4% | +0.3% | -21.1% | +19.5% | +83.1% | +35.5% | +39.3% | +37.4% | +35.1% | +25.1% |
| Net income growth | — | -171.7% | -80.9% | +45.0% | +114.1% | +179.9% | +28.8% | -41.4% | +142.7% | +25.0% |
| EPS growth | — | -173.0% | -80.6% | +44.6% | +101.8% | +152.3% | +18.9% | -48.6% | +111.8% | +21.4% |
| Free cash flow growth | -37.3% | +92.7% | -10.9% | +68.0% | +29.3% | -17.5% | +120.1% | +84.5% | +275.4% | -74.3% |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.